Paper34740784
MicroRNA sequence analysis of plasma exosomes in early Legg-Calvé-Perthes disease.
Huang Q and 9 others. Cell Signal, 2022. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. MicroRNA sequence analysis of plasma exosomes in early Legg-Calvé-Perthes disease. Papers, record 34740784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34740784
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Exosomes | Major topic |
| Legg-Calve-Perthes Disease | Major topic |
| MicroRNAs | Major topic |
| Computational Biology | |
| Humans | |
| Sequence Analysis |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42884134 | A Proposed Convergent Genetic and Molecular Framework for Legg-Calvé-Perthes Disease: A Scoping Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42884134 | PubMed |
| 42791958 | Extracellular Vesicles and Their Role in Osteogenesis. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42791958 | PubMed |
| 41103296 | Metabolomic profiling reveals novel biomarkers and therapeutic targets in Legg-Calvé-Perthes disease: a comprehensive analysis of peripheral blood and endothelial function. | Front Physiol | 2025 | https://conductscience.org/library/papers/41103296 | PubMed |
| 40745900 | Role of Non-Coding RNAs in Pathogenesis, Diagnosis, and Therapy of Legg-Calvé-Perthes Disease: A Systematic Review. | Med Sci Monit | 2025 | https://conductscience.org/library/papers/40745900 | PubMed |
| 40256260 | The multifaceted roles of extracellular vesicles in osteonecrosis of the femoral head. | J Orthop Translat | 2025 | https://conductscience.org/library/papers/40256260 | PubMed |
| 40041162 | Progress in understanding Legg-Calvé-Perthes disease etiology from a molecular and cellular biology perspective. | Front Physiol | 2025 | https://conductscience.org/library/papers/40041162 | PubMed |
| 38668380 | Functional Significance of miR-4693-5p in Targeting HIF1α and Its Link to Rheumatoid Arthritis Pathogenesis. | Noncoding RNA | 2024 | https://conductscience.org/library/papers/38668380 | PubMed |
| 37303951 | Construction of ceRNA network based on RNA-seq for identifying prognostic lncRNA biomarkers in Perthes disease. | Front Genet | 2023 | https://conductscience.org/library/papers/37303951 | PubMed |
| 36766577 | Molecular Biomarkers in Perthes Disease: A Review. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/36766577 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MIR30A | 407029 | PubTator's text mining | https://conductscience.org/library/genes/407029 | NCBI Gene |
| MIR3133 | 100422942 | PubTator's text mining | https://conductscience.org/library/genes/100422942 | NCBI Gene |
| MIR4644 | 100616430 | PubTator's text mining | https://conductscience.org/library/genes/100616430 | NCBI Gene |
| MIR4693 | 100616457 | PubTator's text mining | https://conductscience.org/library/genes/100616457 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34740784
GET https://conductscience.org/api/papers/v1/34740784/authors